LHX Stock Analysis: L3Harris Technologies | NYSE
Aerospace & Defense | NYSE, USA | Market Cap: 51.848m USD | 12M Return: -1.7% | US5024311095 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 407M
EPS Trend: -65.2%
Qual. Beats: 7
Rev. Trend: 96.7%
Qual. Beats: 1
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
L3Harris Technologies (NYSE: LHX) is a U.S.-based defense and aerospace company that supplies mission-critical solutions to government and commercial customers worldwide. It is classified within the GICS Industrials sector (Aerospace & Defense sub-industry) and operates as one of the larger U.S. defense prime contractors serving the Department of Defense and allied governments, a market characterized by long procurement cycles and high regulatory barriers to entry.
The company is organized into three segments. Space & Mission Systems (SMS) integrates satellite and payload capabilities, missile warning and defense systems, and maritime and air mission programs. Missile Solutions (MSL) combines propulsion, hypersonic, and other advanced missile technologies. Communications & Spectrum Dominance (CSD) supplies tactical radios, satellite terminals, end-to-end battlefield networks, helmet-mounted night vision systems, weapon-mounted sights and aiming lasers, and public safety radio equipment.
L3Harris is headquartered in Melbourne, Florida, and traces its origins to 1895. The company was formerly known as Harris Corporation and adopted the L3Harris Technologies, Inc. name in June 2019.
- Missile Solutions revenue accelerates on hypersonic and propulsion demand
- Defense budget growth supports Space & Mission Systems satellite contracts
- Margin expansion continues post L3-Harris merger integration
| Net Income: 2.04b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 3.90 > 1.0 |
| NWC/Revenue: 6.71% < 20% (prev 1.32%; Δ 5.40% < -1%) |
| CFO/TA 0.10 > 3% & CFO 4.18b > Net Income 2.04b |
| Net Debt (10.2b) to EBITDA (4.10b): 2.49 < 3 |
| Current Ratio: 1.18 > 1.5 & < 3 |
| Outstanding Shares: last quarter (188.2m) vs 12m ago 0.23% < -2% |
| Gross Margin: 25.55% > 18% (prev 25.65%; Δ -0.10% > 0.5%) |
| Asset Turnover: 55.44% > 50% (prev 52.72%; Δ 2.72% > 0%) |
| Interest Coverage Ratio: 5.63 > 6 (EBIT TTM 2.95b / Interest Expense TTM 524.0m) |
| A: 0.04 (Total Current Assets 10.1b - Total Current Liabilities 8.52b) / Total Assets 42.9b |
| B: 0.11 (Retained Earnings 4.72b / Total Assets 42.9b) |
| C: 0.07 (EBIT TTM 2.95b / Avg Total Assets 42.1b) |
| D: 0.94 (Book Value of Equity 20.9b / Total Liabilities 22.1b) |
| Altman-Z'' = 2.06 = BBB |
| DSRI: 0.97 (Receivables 5.62b/5.39b, Revenue 23.3b/21.7b) |
| GMI: 1.00 (GM 25.65% / 25.55%) |
| AQI: 0.94 (AQ_t 0.70 / AQ_t-1 0.75) |
| SGI: 1.07 (Revenue 23.3b / 21.7b) |
| TATA: -0.05 (NI 2.04b - CFO 4.18b) / TA 42.9b) |
| Beneish M = -3.03 (Cap -4..+1) = AA |
As of November 03, 2026, the stock is trading at USD 278.96 with a total of 1,529,957 shares traded. Over the past week, the price has changed by +7.20%, over one month by +17.90%, over three months by +0.88% and over the past year by -1.73%.
Current recommended Stop Loss: 270.80 (which is 2.9% or 1.3 ATR below the current price).
L3Harris Technologies has received a consensus analysts rating of 4.15. Therefore, it is recommended to buy LHX.
- StrongBuy: 11
- Buy: 1
- Hold: 8
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 323.7 | 16% |
P/E Trailing = 26.267
P/E Forward = 19.5313
P/S = 2.2609
P/B = 2.4409
P/EG = 1.3009
Revenue TTM = 23.3b USD
EBIT TTM = 2.95b USD
EBITDA TTM = 4.10b USD
Long Term Debt = 9.18b USD (from longTermDebt, last quarter)
Short Term Debt = 1.81b USD (from shortTermDebt, last quarter)
Debt = 11.7b USD (from shortLongTermDebtTotal, last quarter) + Leases 736.0m
Net Debt = 10.2b USD (calculated: Debt 11.7b - CCE 1.52b)
Enterprise Value = 62.1b USD (51.8b + Debt 11.7b - CCE 1.52b)
Interest Coverage Ratio = 5.63 (Ebit TTM 2.95b / Interest Expense TTM 524.0m)
EV/FCF = 17.05x (Enterprise Value 62.1b / FCF TTM 3.64b)
FCF Yield = 5.87% (FCF TTM 3.64b / Enterprise Value 62.1b)
FCF Margin = 15.60% (FCF TTM 3.64b / Revenue TTM 23.3b)
Net Margin = 8.76% (Net Income TTM 2.04b / Revenue TTM 23.3b)
Gross Margin = 25.55% ((Revenue TTM 23.3b - Cost of Revenue TTM 17.4b) / Revenue TTM)
Gross Margin QoQ = 26.60% (prev 25.54%)
Tobins Q-Ratio = 1.45 (Enterprise Value 62.1b / Total Assets 42.9b)
Interest Expense / Debt = 4.47% (Interest Expense 524.0m / Debt 11.7b)
Taxrate = 15.68% (380.0m / 2.42b)
NOPAT = 2.49b (EBIT 2.95b * (1 - 15.68%))
Current Ratio = 1.18 (Total Current Assets 10.1b / Total Current Liabilities 8.52b)
Debt / Equity = 0.56 (Debt 11.7b / totalStockholderEquity, last quarter 20.9b)
Debt / EBITDA = 2.49 (Net Debt 10.2b / EBITDA 4.10b)
Debt / FCF = 2.81 (Net Debt 10.2b / FCF TTM 3.64b)
Total Stockholder Equity = 19.9b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.86% (Net Income 2.04b / Total Assets 42.9b)
RoE = 10.26% (Net Income TTM 2.04b / Total Stockholder Equity 19.9b)
RoCE = 10.13% (EBIT 2.95b / Capital Employed (Equity 19.9b + L.T.Debt 9.18b))
RoIC = 7.09% (NOPAT 2.49b / Invested Capital 35.1b)
WACC = 5.36% (E(51.8b)/V(63.6b) * Re(5.72%) + D(11.7b)/V(63.6b) * Rd(4.47%) * (1-Tc(0.16)))
Discount Rate = 5.72% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -86.58 | Cagr: -0.60%
[DCF] Terminal Value 77.97% ; FCFF base≈2.94b ; Y1≈3.37b ; Y5≈4.96b
[DCF] Fair Price = 346.0 (EV 74.6b - Net Debt 10.2b = Equity 64.4b / Shares 186.2m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -65.20 | EPS CAGR: -4.42% | SUE: 2.40 | # QB: 7
Revenue Correlation: 96.67 | Revenue CAGR: 5.70% | SUE: 0.88 | # QB: 1
EPS current Quarter (2027-03-31): EPS=3.06 | Chg30d=-0.86% | Revisions=-50% | Analysts=4
EPS current Year (2026-12-31): EPS=11.90 | Chg30d=-1.60% | Revisions=-25% | GrowthEPS=+10.9% | GrowthRev=+7.7%
EPS next Year (2027-12-31): EPS=13.49 | Chg30d=-0.36% | Revisions=+17% | GrowthEPS=+13.3% | GrowthRev=+7.3%
[Analyst] Revisions Ratio: -30% (up=2, down=5)